The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients

202415 citationsJournal Articlegold Open Access

Authors

Osnat Elyashiv · Tel Aviv University

Natalie Aleohin · Tel Aviv Sourasky Medical Center

Z Migdan · Wolfson Medical Center

Sophia Leytes · Tel Aviv University

Ofri Peled · Tel Aviv University

Ori Tal · Wolfson Medical Center

Tally Levy ·

Abstract

Platinum resistance is an important prognostic factor in women with EOC. Patients with SPR acquire the same poor treatment outcome as with PPR. There is a great need for future research efforts to discover novel strategies and biological treatments to reverse resistance and improve survival.

Topics & Keywords

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Lymphoma Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancers

Volume 16, Issue 3, pp. 641-641

DOI: 10.3390/cancers16030641

Field-Weighted Citation Impact: 8.22